Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ORPHENADRINE vs OXALIPLATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ORPHENADRINE vs OXALIPLATIN: Safety Overview

Metric ORPHENADRINE OXALIPLATIN
Total FAERS Reports 584 56,406
Deaths Reported 121 6,501
Death Rate 20.7% 11.5%
Hospitalizations 159 21,980
Average Patient Age 47.9 yrs 61.5 yrs
% Female Patients 79.3% 42.1%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 28, 2011
Manufacturer Sandoz Inc Camber Pharmaceuticals, Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued Discontinued